Status:
NOT_YET_RECRUITING
A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi
Lead Sponsor:
Mayo Clinic
Conditions:
Ureteroscopy
Post Operative Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal post...
Eligibility Criteria
Inclusion
- Patients who are diagnosed with kidney or ureteral stones confirmed on imaging (CT of the abdomen or pelvis) and who elect for definitive treatment via ureteroscopy with placement of ureteral stent.
- Age 18 years or older
- Patients of either gender
- Patients of all ethnic backgrounds
- Cable of giving informed consent
- Capable and willing to fulfill the requirements of the study.
Exclusion
- History of chronic pain
- Chronic use of opioids or other pain medication (\>12 weeks)
- Known allergies to corticosteroids.
- Known or suspected pregnancy
- Inability to give informed consent or unable to meet requirements of the study for any reason.
- Bilateral ureteroscopy
- Current Corticosteroid Use
- Diabetic patients who are insulin dependent
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT07223580
Start Date
December 1 2025
End Date
December 1 2027
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259